What one share of Vyome Holdings holds
Lifesciences Inc. (now known as Vyome Holdings, Inc.) (the “Company”) completed the merger pursuant to the Agreement and Plan
Vyome Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.02 |
|---|---|
| Profit | −$2.15 |
| Cash and investments | $1.12 |
| Book value | $1.04 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$110.87 | $0.42 | −$165.55 | — | — |
| 2025 | $0.15 | −$4.75 | — | — | — | $0.64 |
Common questions about Vyome Holdings
How much does one share of Vyome Holdings earn?
Over the last 12 months, Vyome Holdings lost $2.15 for each share on $0.02 of sales.
Does Vyome Holdings pay a dividend?
Vyome Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Vyome Holdings’s book value per share?
Vyome Holdings’s book value is $1.04 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Vyome Holdings have?
Each share of Vyome Holdings has $1.12 of cash and investments, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.